Indium (¹¹¹In) satumomab pendetide

Indium (¹¹¹In) satumomab pendetide (trade name OncoScint CR103) is a mouse monoclonal antibody which is used for cancer diagnosis.^[1] The antibody, satumomab, is linked to pendetide, a derivative of DTPA. Pendetide acts as a chelating agent for the radionuclide indium-111.

References

^ García-Fernández R, Luna-Pérez P, Hernández-Hernández DM, Iwasaki-Otake L, Pichardo-Romero P, Rodríguez-Ramirez S (2002). "[Usefulness of scintigraphy images with 111In-CYT-103 in the diagnosis of colonic and rectal recurrence]". Gaceta Médica de México. 138 (2): 139–44. PMID 12001423.

This nuclear medicine article is a stub. You can help Wikipedia by expanding it.

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.